TBIO
TELESIS BIO INC
stockOTC
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna's ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna's genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna's reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1M | 0.00 | 2026-09-10 | +1000.00% | -11444.096 |
| 3M | 0.01 | 2026-07-09 | +10.00% | -879.206 |
| 6M | 0.05 | 2026-04-15 | -78.43% | 298.367 |
| 1Y | 0.01 | 2025-10-09 | -4.76% | 79.085 |
| 2Y | 2.25 | 2024-10-08 | -99.51% | — |
| 5Y | 672.48 | 2021-09-13 | -100.00% | 5.091 |
TELESIS BIO INC (OTC:TBIO) stock price today is $0.01, and today's volume is 205. TBIO is up 10900.000% today. The 30 day average volume is 1,891. TBIO market cap is $19,502 with 1.77M shares outstanding.